Recurrent Endometrial Stromal Sarcoma: Treatment with a Progestin and Gonadotropin Releasing Hormone Agonist

المؤلفون المشاركون

DiSaia, Philip John
duPont, Nefertiti Chianti

المصدر

Complexity

العدد

المجلد 2010، العدد 2010 (31 ديسمبر/كانون الأول 2010)، ص ص. 1-3، 3ص.

الناشر

Hindawi Publishing Corporation

تاريخ النشر

2010-05-17

دولة النشر

مصر

عدد الصفحات

3

التخصصات الرئيسية

الفلسفة

الملخص EN

Endometrial stromal sarcoma (ESS) formerly classified as low-grade endometrial stromal sarcoma is a rare uterine malignancy with a good prognosis despite a tendency to recur.

Primary surgical management for ESS includes total abdominal hysterectomy and bilateral salpingo-oophorectomy.

Patients with ESS have long disease-free survival rates when treated with primary surgical therapy, but nearly fifty percent of these patients will recur.

We present the case of a patient with recurrent ESS who had an excellent response to combined therapy with megestrol and leuprolide.

نمط استشهاد جمعية علماء النفس الأمريكية (APA)

duPont, Nefertiti Chianti& DiSaia, Philip John. 2010. Recurrent Endometrial Stromal Sarcoma: Treatment with a Progestin and Gonadotropin Releasing Hormone Agonist. Complexity،Vol. 2010, no. 2010, pp.1-3.
https://search.emarefa.net/detail/BIM-989728

نمط استشهاد الجمعية الأمريكية للغات الحديثة (MLA)

duPont, Nefertiti Chianti& DiSaia, Philip John. Recurrent Endometrial Stromal Sarcoma: Treatment with a Progestin and Gonadotropin Releasing Hormone Agonist. Complexity No. 2010 (2010), pp.1-3.
https://search.emarefa.net/detail/BIM-989728

نمط استشهاد الجمعية الطبية الأمريكية (AMA)

duPont, Nefertiti Chianti& DiSaia, Philip John. Recurrent Endometrial Stromal Sarcoma: Treatment with a Progestin and Gonadotropin Releasing Hormone Agonist. Complexity. 2010. Vol. 2010, no. 2010, pp.1-3.
https://search.emarefa.net/detail/BIM-989728

نوع البيانات

مقالات

لغة النص

الإنجليزية

الملاحظات

Includes bibliographical references

رقم السجل

BIM-989728